Skip to main content


Correction to: Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET

Article metrics

The original article was published in Radiation Oncology 2018 13:159


Following the publication of this article [1], the authors noticed that Figs. 2, 3, 4 and 5 were in the incorrect order and thus had incorrect captions.

Fig. 2

Representative example of imaging modalities MRI T1, T2*, and FMISO-PET. Primary tumour and lymph node metastasis (pt. 5, tonsillar carcinoma) at week 0, 2, and 5 (upper, middle, lower panel): co-registered image sets from MRI T1, MRI T2*, FMISO-PET (left to right). Red contours: GTV-T, GTV-LN. Blue contour: HSV-LN

Fig. 3

Time course of T2* values within volumes. T2* mean ± STD within tumour, lymph nodes and normal tissue for all patients (n = 10)

Fig. 4

Hypoxic tumour subvolumes: T2* values vs. FDG uptake and FMISO uptake. T2* values (ms) were lower and FDG uptake was higher within hypoxic tumour subvolumes as compared to non-hypoxic tumour subvolumes (*p = 0.051, **p = 0.026). FMISO uptake was higher within hypoxic tumour subvolumes than within non-hypoxic tumour subvolumes (***p = 0.029, p = 0.072, ****p = 0.003, p = 0.0001)

Fig. 5

Correlation of FMISO uptake with mean T2* and FDG uptake. Plots showing correlation within GTV-T at baseline

The images that were incorrectly published as Figs. 2, 3, 4 and 5 should have been published as Figs. 4, 5, 2 and 3 respectively.

The correct versions of Figs. 2, 3, 4 and 5 with captions have been included in this Correction.

The original article has been corrected.


Author information

Correspondence to Nicole Wiedenmann.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wiedenmann, N., Bunea, H., Rischke, H.C. et al. Correction to: Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET. Radiat Oncol 13, 183 (2018) doi:10.1186/s13014-018-1134-7

Download citation


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.